Citigroup analyst Ralph Giacobbe maintained a Buy rating on Tenet Healthcare (NYSE: THC) today and set a price target of $37. The company’s shares closed yesterday at $31.87, close to its 52-week high of $32.17.
Giacobbe has an average return of 29.2% when recommending Tenet Healthcare.
According to TipRanks.com, Giacobbe is ranked #428 out of 4787 analysts.
Currently, the analyst consensus on Tenet Healthcare is Moderate Buy and the average price target is $27.60, representing a -13.4% downside.
In a report issued on May 2, Leerink Partners also reiterated a Buy rating on the stock with a $40 price target.
Find more picks by Best Performing Analysts >>
The company has a one-year high of $32.17 and a one-year low of $12.25. Currently, Tenet Healthcare has an average volume of 2.5M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.
